Published online Feb 28, 2026. doi: 10.4329/wjr.v18.i2.116462
Revised: December 10, 2025
Accepted: January 9, 2026
Published online: February 28, 2026
Processing time: 105 Days and 17.5 Hours
Soft-tissue sarcomas (STS) are heterogeneous mesenchymal malignancies for which surgery remains the mainstay of curative treatment, yet recurrence and mortality rates remain substantial. Nutritional status and body composition measured via routine blood tests and computed tomography-derived metrics such as skeletal muscle and adipose tissue areas have emerged as important determinants of outcomes in cancer. Advanced machine-learning methods can integrate high-dimensional nutritional and radiologic variables to improve individualized survival prediction.
To identify prognostic value of nutrition-associated factors for patients with STS treated with excision and to construct a predictive model for nutritional ass
We retrospectively included 638 patients who were diagnosed with STS and underwent surgical excision from January 2009 to June 2018. Nutrition-associated indicators from peripheral blood tests and routine computed tomography were collected. The primary outcome was overall survival (OS). The secondary out
The RSF analysis identified stage, hospital duration, subtype, body mass index, and tumour size as important variables for OS. The RSF-based nomogram on nutritional indexes for various clinical outcomes showed consistent calibration capacities on calibration plots and great discriminative abilities on the C-index and Brier score.
Our study implicated the prognostic value of multiple nutritional assessment indexes for prediction of clinical outcomes in STS, and patients’ nutrition status need long-term surveillance and management.
Core Tip: This study explored the prognostic value of various nutritional assessment indicators for patients with soft tissue sarcomas receiving surgical resection. We constructed the prediction model for short- and long-term prognoses via multi-sided variables with potential prognostication in patients with resectable sarcomas. We applied machine learning methods to increase the prediction abilities of our model for identification of individual survival risk. The sample size was nearly 700 larger than most studies about nutritional prognostic factors especially for sarcomas.
